380

Rehovot

0 studies enrolling now · 2 studies all time

What they study most

Systemic Lupus Erythematosus

Studies at this site

• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus — Completed
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus — Completed